BIODISTRIBUTION OF AN ULTRASMALL SUPERPARAMAGNETIC IRON-OXIDE COLLOID, BMS-180549, BY DIFFERENT ROUTES OF ADMINISTRATION

被引：85

作者：

BENGELE, HH

PALMACCI, S

ROGERS, J

JUNG, CW

CRENSHAW, J

JOSEPHSON, L

机构：

[1] Advanced Magnetics Inc., Cambridge, MA 02138

来源：

MAGNETIC RESONANCE IMAGING | 1994年 / 12卷 / 03期

关键词：

LYMPHATIC; SUPERPARAMAGNETIC; CONTRAST AGENT;

D O I：

10.1016/0730-725X(94)92537-2

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The ultrasmall superparamagnetic iron oxide colloid BMS 180549 can be found in Lymph nodes by either subcutaneous (SC) or intravenous (IV) injection. With an SC injection in the front extremities, the axillary and brachial nodes attain the highest accumulations of the agent. With an SC injection in the rear extremities, the popliteal, iliac, and axillary nodes attain highest accumulations of the agent. With IV injection of the agent, the iliac, mediastinal and mesenteric nodes attain highest accumulations of the agent. Though the spleen is not involved with the drainage of the interstitial space near the site of SC injections, the mobility of BMS 180549 from such injection sites increases splenic relaxation rates. Based on a knowledge of the lymphatic system, a route of administration of BMS 180549 can be chosen to maximize the delivery of the agent to specific lymph nodes.

引用

页码：433 / 442

页数：10

共 20 条

[11]

Fahlvik, Holtz, Klavness, Relaxation efficacy of paramagnetic and superparamagnetic microspheres in liver and spleen, Magn. Reson. Imaging, 8, pp. 363-369, (1990)

[12]

Majumdar, Et al., A quantitative study of relaxation rate enhancement produced by iron oxide particles in polyacrylamide gels and tissue, Magn. Reson. Med., 9, pp. 185-202, (1989)

[13]

Groman, Josephson, Lewis, Biologically degradable superparamagnetic materials for use in clinical applications, Biologically degradable superparamagnetic materials for use in clinical applications, (1989)

[14]

Fretz, Et al., Superparamagnetic iron oxide-enhanced MR imaging: Pulse sequence optimization for detection of liver cancer, Radiology, 172, pp. 393-397, (1989)

[15]

O'Hagan, Chirsty, Davis, Particulates and lymphatic drug delivery, Lymphatic Transport of Drugs, pp. 279-315, (1992)

[16]

Seymour, Et al., Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylacmide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats, J. Biomed. Mater. Res., 21, pp. 1341-1358, (1987)

[17]

Ege, Lymphoscintigraphy — Techniques and applications in the management of breast cancer, Semin. Nucl. Med., 13, pp. 26-34, (1983)

[18]

Lee, Et al., Lymph nodes: microstructural anatomy at MR imaging, Radiology, 178, pp. 519-522, (1991)

[19]

Hamm, Et al., MR lymphography with iron oxide particles: Dose-response studies and pulse sequence optimization in rabbits, Am. J. Roentgenol., 158, pp. 183-190, (1992)

[20]

Taupitz, Et al., MR lymphography using iron oxide particles, Acta Radiol., 34, pp. 10-15, (1993)

← 1 2 →